Author

David Foley

Observed names: D. Foley, David W Foley, David W. Foley, David William Foley, Foley, David, Foley, David W.

Observed institutions: Queen's University Belfast, University of Nottingham, University of Dundee, University of Manchester, Keele University, Cardiff University

ORCID: 0000-0001-8449-4754

Observed ORCID: 0000-0001-8449-4754

OpenAlex ID: A5087663058

An energy supply network of nutrient absorption coordinated by calcium and T1R taste receptors in rat small intestine

2008 · Oliver J. Mace, Norma Lister, et al. · The Journal of Physiology · 164

Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal Structures, Structure–Activity Relationship, and Anticancer Activities

2013 · Hao Shao, Shenhua Shi, et al. · Journal of Medicinal Chemistry · 132

Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies

2013 · Shahin Assefnia, Sivanesan Dakshanamurthy, et al. · Oncotarget · 71

PDF

Synthesis, structure–activity relationship and biological evaluation of 2,4,5-trisubstituted pyrimidine CDK inhibitors as potential anti-tumour agents

2013 · Hao Shao, Shenhua Shi, et al. · European Journal of Medicinal Chemistry · 61

Bioavailability Through PepT1: The Role of Computer Modelling in Intelligent Drug Design

2010 · David Foley, Jeyaganesh Rajamanickam, et al. · Current Computer - Aided Drug Design · 37

Comparative Analysis of Small-Molecule LIMK1/2 Inhibitors: Chemical Synthesis, Biochemistry, and Cellular Activity

2022 · Ross Collins, Hyunah Lee, et al. · Journal of Medicinal Chemistry · 28

Structure-based design of highly selective 2,4,5-trisubstituted pyrimidine CDK9 inhibitors as anti-cancer agents

2021 · Hao Shao, David W. Foley, et al. · European Journal of Medicinal Chemistry · 28

PDF

Discovery of super soft-drug modulators of sphingosine-1-phosphate receptor 1

2018 · Mark Bell, David Foley, et al. · Bioorganic & Medicinal Chemistry Letters · 26

PDF

True or false? Challenges and recent highlights in the development of aspirin prodrugs

2020 · Steffan Willetts, David W. Foley · European Journal of Medicinal Chemistry · 25

Thiodipeptides targeting the intestinal oligopeptide transporter as a general approach to improving oral drug delivery

2018 · David W. Foley, Ravindra B. Pathak, et al. · European Journal of Medicinal Chemistry · 21

PDF

The in vitro transport of model thiodipeptide prodrugs designed to target the intestinal oligopeptide transporter, PepT1

2009 · David Foley, Myrtani Pieri, et al. · Organic & Biomolecular Chemistry · 21

Targeting ketone drugs towards transport by the intestinal peptide transporter, PepT1

2009 · David Foley, Patrick Bailey, et al. · Organic & Biomolecular Chemistry · 17

PDF

Discovery of Soft-Drug Topical Tool Modulators of Sphingosine-1-phosphate Receptor 1 (S1PR1)

2019 · Mark Bell, David Foley, et al. · ACS Medicinal Chemistry Letters · 9

Discovery of MDI-114215: A Potent and Selective LIMK Inhibitor To Treat Fragile X Syndrome

2024 · Alex G. Baldwin, David W. Foley, et al. · Journal of Medicinal Chemistry · 8

PDF

A cyclosporine derivative is a substrate of the oligopeptide transporter PepT1

2016 · David W. Foley, Isabel Bermudez, et al. · MedChemComm · 5

Tetrahydropyrazolopyridinones as a Novel Class of Potent and Highly Selective LIMK Inhibitors

2025 · Alex G. Baldwin, David W. Foley, et al. · Journal of Medicinal Chemistry · 4

PDF

Communicating Our Science to Our Customers: Drug Discovery in Five Simple Experiments

2017 · Lesley-Anne Pearson, David William Foley · ACS Medicinal Chemistry Letters · 3

274 Synthesis and in Vitro Evaluation of Selective CDK9 Inhibitors

2012 · H. Shao, A.Y. Abbas, et al. · European Journal of Cancer · 1

Anticancer Therapeutics. Edited by Sotiris Missailidis.

2009 · David Foley · ChemMedChem · 1

Administration in fed state but not controlled release in the colon increases oral bioavailability of DF030263, a promising drug candidate for chronic lymphocytic leukemia

2021 · Jong Bong Lee, Xiaowei Zang, et al. · European Journal of Pharmaceutics and Biopharmaceutics

Abstract A045: Cadherin-11, a common therapeutic target in poor prognosis malignancies and rheumatoid arthritis

2013 · Shahin Assefnia, Sivanesan Dakshanamurthy, et al. · Molecular Cancer Research

Abstract 697: Synthesis and biological evaluation of 2,4,5-substituted pyrimidines as highly selective CDK9 inhibitors for cancer treatment.

2013 · Hao Shao, David Foley, et al. · Cancer Research

Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal Structures, Structure-Activity Relationship, and Anticancer Activities

2013 · Hao Shao, Shenhua Shi, et al. · Newcastle University ePrints (Newcastle Univesity)

Works count: 28

Citation count: 662

H-index: 12

I10-index: 12